Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
E. Baudin, M. Caplin, R. Garcia-Carbonero, N. Fazio, P. Ferolla, P. L. Filosso, A. Frilling, W. W. de Herder, D. Hörsch, U. Knigge, C. M. Korse, E. Lim, C. Lombard-Bohas, M. Pavel, J. Y. Scoazec, A. Sundin & A. Berruti, on behalf of the ESMO Guidelines Committee Endocrine Oncology and Nuclear Medicine Unit, Gustave Roussy, Villejuif, France; Centre for Gastroenterology, Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK; Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Madrid, Spain; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours, European Institute of Oncology IEO, IRCCS, Milan; Multidisciplinary NET Group, Department of Medical Oncology, Umbria Regional Cancer Network and University of Perugia, Perugia; Department of Surgical Sciences Unit of Thoracic Surgery Corso Dogliotti, University of Torino, Torino, Italy; Department of Surgery and Cancer, Imperial College London, London, UK; Department of Internal Medicine, Sector of Endocrinology, Erasmus MC, ENETS Centre of Excellence, Rotterdam, The Netherlands; ENETS Centre of Excellence Zentralklinik Bad Berka, Bad Berka, Germany; Department of Surgery and Department of Endocrinology, ENETS Centre of Excellence, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Imperial College and the Academic Division of Thoracic Surgery, The Royal Brompton Hospital, London, UK; Cancer Institute Hospices Civils de Lyon, Hôpital E Herriot, Lyon, France; Department of Medicine 1, Endocrinology, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Pathology, Gustave Roussy, Villejuif, France; Department of Radiology and Nuclear Medicine, Department of Surgical Sciences (IKV), Uppsala University, Uppsala, Sweden; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia, Brescia, Italy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Yao, J. C., Fazio, N., Singh, S., Buzzoni, R., Carnaghi, C., Wolin, E., Tomasek, J., Raderer, M., Lahner, H., Voi, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00817-x · Cited by 1,292
Self-citationPavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Self-citationPavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Self-citationTravis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
Imhof, A., Brunner, P., Marincek, N., Briel, M., Schindler, C., Rasch, H., Mäcke, H. R., Rochlitz, C., Müller-Brand, J., & Walter, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7873 · Cited by 641
ESMO-magnitude of clinical benefit scale version 1.1
Cherny, N. I., Dafni, U., Bogaerts, J., Latino, N. J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M. J., & de Vries, E. G. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx310 · Cited by 641
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Brabander, T., van der Zwan, W. A., Teunissen, J. J. M., Kam, B. L. R., Feelders, R. A., de Herder, W. W., van Eijck, C. H. J., Franssen, G. J. H., Krenning, E. P., & Kwekkeboom, D. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2743 · Cited by 614
Self-citationRecommendations for management of patients with neuroendocrine liver metastases
Frilling, A., Modlin, I. M., Kidd, M., Russell, C., Breitenstein, S., Salem, R., Kwekkeboom, D., Lau, W.-Y., Klersy, C., Vilgrain, V., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70362-0 · Cited by 527
Self-citationFrequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
Halperin, D. M., Shen, C., Dasari, A., Xu, Y., Chu, Y., Zhou, S., Shih, Y.-C. T., & Yao, J. C. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30110-9 · Cited by 390
Sun, W., Lipsitz, S., Catalano, P., Mailliard, J. A., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.616 · Cited by 357
Kwekkeboom, D. J., Krenning, E. P., Lebtahi, R., Komminoth, P., Kos-Kudła, B., de Herder, W. W., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225951 · Cited by 349
Self-citationHicks, R. J., Kwekkeboom, D. J., Krenning, E., Bodei, L., Grozinsky-Glasberg, S., Arnold, R., Borbath, I., Cwikla, J., Toumpanakis, C., Kaltsas, G., et al. (2017) · Neuroendocrinology · doi:10.1159/000475526 · Cited by 336
Self-citationAre G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise, F.-L., Duvillard, P., Foucan, L., Hadoux, J., Chougnet, C. N., Leboulleux, S., Malka, D., Guigay, J., Goere, D., Debaere, T., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0027 · Cited by 325
Self-citationNeuroendocrine Carcinomas (Carcinoid Tumor) of the Thymus
Moran, C. A., & Suster, S. (2000) · American Journal of Clinical Pathology · doi:10.1309/3pdn-pmt5-eqtm-h0cd · Cited by 318
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Fernandez-Cuesta, L., Peifer, M., Lu, X., Sun, R., Ozretić, L., Seidel, D., Zander, T., Leenders, F., George, J., Müller, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4518 · Cited by 317
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
Bushnell, D. L., O'Dorisio, T. M., O'Dorisio, M. S., Menda, Y., Hicks, R. J., Van Cutsem, E., Baulieu, J.-L., Borson-Chazot, F., Anthony, L., Benson, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8585 · Cited by 306
Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel, C. G., & Hanley, J. A. (1979) · PubMed · Cited by 277
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
Engstrom, P. F., Lavin, P. T., Moertel, C. G., Folsch, E., & Douglass, H. O. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.11.1255 · Cited by 270
Korse, C. M., Taal, B. G., van Velthuysen, M.-L. F., & Visser, O. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.022 · Cited by 239
Self-citationSimbolo, M., Mafficini, A., Sikora, K. O., Fassan, M., Barbi, S., Corbo, V., Mastracci, L., Rusev, B., Grillo, F., Vicentini, C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4853 · Cited by 233
Young, J., Haissaguerre, M., Viera-Pinto, O., Chabre, O., Baudin, E., & Tabarin, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0877 · Cited by 232
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
Rindi, G., Klersy, C., Inzani, F., Fellegara, G., Ampollini, L., Ardizzoni, A., Campanini, N., Carbognani, P., De Pas, T. M., Galetta, D., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0246 · Cited by 217
Kaltsas, G., Caplin, M., Davies, P., Ferone, D., Garcia-Carbonero, R., Grozinsky-Glasberg, S., Hörsch, D., Tiensuu Janson, E., Kianmanesh, R., Kos-Kudla, B., et al. (2017) · Neuroendocrinology · doi:10.1159/000461583 · Cited by 199
Self-citationThymic Neuroendocrine Tumors: A SEER Database Analysis of 160 Patients
Gaur, P., Leary, C., & Yao, J. C. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181dd4ec4 · Cited by 180
Yao, J. C., Guthrie, K. A., Moran, C., Strosberg, J. R., Kulke, M. H., Chan, J. A., LoConte, N., McWilliams, R. R., Wolin, E. M., Mattar, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.4072 · Cited by 166
Ferollà, P., Brizzi, M. P., Meyer, T., Mansoor, W., Mazières, J., Cao, C. D., Léna, H., Berruti, A., Damiano, V., Buikhuisen, W. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30681-2 · Cited by 153
Self-citationExperience in treatment of metastatic pulmonary carcinoid tumors
Granberg, D. O., Eriksson, B., Wilander, E., Grimfjärd, P., Fjällskog, M.-L., Öberg, K., & Skogseid, B. M. (2001) · Annals of Oncology · doi:10.1023/a:1012569909313 · Cited by 147
Fairweather, M., Swanson, R. S., Wang, J., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5839-x · Cited by 138
Thermal ablation techniques: a curative treatment of bone metastases in selected patients?
Deschamps, F., Farouil, G., Ternès, N., Gaudin, A., Hakimé, A., Tselikas, L., Teriitehau, C. A., Baudin, É., Auperin, A., & de Baère, T. (2014) · European Radiology · doi:10.1007/s00330-014-3202-1 · Cited by 137
Simbolo, M., Barbi, S., Fassan, M., Mafficini, A., Alì, G., Vicentini, C., Sperandio, N., Corbo, V., Rusev, B. C., Mastracci, L., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.003 · Cited by 111
Fazio, N., Buzzoni, R., Fave, G. D., Tesselaar, M. E. T., Wolin, E. M., Cutsem, E. V., Tomassetti, P., Strosberg, J., Voi, M., Bubuteishvili‐Pacaud, L., et al. (2017) · Cancer Science · doi:10.1111/cas.13427 · Cited by 110
Self-citationSpada, F., Antonuzzo, L., Marconcini, R., Radice, D., Antonuzzo, A., Ricci, S., Costanzo, F. D., Fontana, A., Gelsomino, F., Luppi, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000444087 · Cited by 100
Self-citationGlobal Consultation on Cancer Staging: promoting consistent understanding and use
Brierley, J. D., O’Sullivan, B., Asamura, H., Byrd, D. R., Huang, S. H., Lee, A., Piñeros, M., Mason, M. D., de Moraes, F. Y., Rösler, W., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0253-x · Cited by 98
Pavel, M. E., Singh, S., Strosberg, J., Bubuteishvili‐Pacaud, L., Degtyarev, E., Neary, M. P., Carnaghi, C., Tomášek, J., Wolin, E. M., Raderer, M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30471-0 · Cited by 93
Self-citationNaing, A., Gainor, J. F., Gelderblom, H. A. J., Forde, P. M., Butler, M. O., Lin, C., Sharma, S., de Olza, M. O., Varga, A., Taylor, M. H., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000530 · Cited by 89
Berruti, A., Fazio, N., Ferrero, A., Brizzi, M. P., Volante, M., Nobili, E., Tozzi, L., Bodei, L., TORTA, M., D’Avolio, A., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-184 · Cited by 88
Self-citationCharacterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Robelin, P., Hadoux, J., Forestier, J., Planchard, D., Hervieu, V., Berdelou, A., Scoazec, J., Valette, P., Leboulleux, S., Ducreux, M. P., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.02.002 · Cited by 75
Self-citationMolecular Classification of Neuroendocrine Tumors of the Thymus
Dinter, H., Bohnenberger, H., Beck, J., Bornemann-Kolatzki, K., Schütz, E., Küffer, S., Klein, L., Franks, T. J., Roden, A. C., Emmert, A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.04.015 · Cited by 75
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms
Al‐Toubah, T., Morse, B. G., & Strosberg, J. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0361 · Cited by 73
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
Zandee, W. T., Kamp, K., van Adrichem, R. C. S., Feelders, R. A., & de Herder, W. W. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0538 · Cited by 72
Filosso, P. L., Rena, O., Guerrera, F., Moreno, P., Sagan, D., Raveglia, F., Brunelli, A., Welter, S., Gust, L., Pompili, C., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu404 · Cited by 71
Self-citationSabet, A., Haug, A. R., Eiden, C., Auernhammer, C. J., Simon, B., Bartenstein, P., Biersack, H. J., & Ezziddin, S. (2017) · PubMed · Cited by 56
Frilling, A., Clift, A. K., Braat, A. J. A. T., Alsafi, A., Wasan, H. S., AL-NAHHAS, A. M., Thomas, R. H., Drymousis, P., Habib, N., & Tait, P. (2019) · HPB · doi:10.1016/j.hpb.2018.12.014 · Cited by 54
Self-citationCattoni, M., Vallières, E., Brown, L. M., Sarkeshik, A. A., Margaritora, S., Siciliani, A., Filosso, P. L., Guerrera, F., Imperatori, A. S., Rotolo, N., et al. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.08.102 · Cited by 36
Self-citationXu, J., Shen, L., Zhou, Z., Li, J., Bai, C., Chi, Y., Li, Z., Xu, N., Jia, R., Li, E., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz394.073 · Cited by 18
Filosso, P. L., Öberg, K., Malczewska, A., Lewczuk, A., Roffinella, M., Aslanian, H. R., & Bodei, L. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa018 · Cited by 13
Self-citationFerollà, P., Berruti, A., Spada, F., Brizzi, M. P., Ibrahim, T., Colao, A. A. L., Faggiano, A., Marconcini, R., Vaccaro, V., Giuffrida, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.1374 · Cited by 11
Self-citation
Cited by
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives
Modica, R., Liccardi, A., Minotta, R., Cannavale, G., Benevento, E., & Colao, A. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2099840 · Cited by 37
Metadata
- Authors
- Baudin, E., Caplin, M., Garcia-Carbonero, R., Fazio, N., Ferolla, P., Filosso, P. L., Frilling, A., de Herder, W. W., Hörsch, D., Knigge, U., Korse, C. M., Lim, E., Lombard-Bohas, C., Pavel, M., Scoazec, J. Y., Sundin, A., & Berruti, A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 32
- Issue
- 4
- Pages
- 439-451
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W3123566622
- Cited by
- 270
- References
- 51
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.